Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Thyroid dysfunction in the elderly: quantifying the association between sub-clinical disease and (i) atrial fibrillation (and thus stroke) (ii) depression and (iii) cognitive dysfunction. A community based survey and clinical trial of thyroxine therapy
ISRCTN ISRCTN23090699
ClinicalTrials.gov identifier
Public title Thyroid dysfunction in the elderly: quantifying the association between sub-clinical disease and (i) atrial fibrillation (and thus stroke) (ii) depression and (iii) cognitive dysfunction. A community based survey and clinical trial of thyroxine therapy
Scientific title
Acronym BETS (Birmingham Elderly Thyroid Study)
Serial number at source 226/657
Study hypothesis Not provided at time of registration
Lay summary
Ethics approval Not provided at time of registration
Study design Community based survey and randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Thyroid dysfunction
Participants - inclusion criteria Phase 1: Aged 65+
Phase 2a: Patients identified in Phase 1 to be suffering from sub-clinical hyperthyroidism
Phase 2b: Patients identified in Phase 1 to be suffering from sub-clinical hypothyroidism
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2005
Anticipated end date 01/01/2006
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Intervention: Thyroxine replacement therapy. Dose to be increased by 25 mcg steps during 6 monthly period of monthly monitoring of thyroid function

Control: As for intervention group but placebo
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The Health Foundation (UK)
Trial website
Publications Results for community based survey: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17003083
Contact name Professor  James V  Parle
  Address Department of Primary Care and General Practice
University of Birmingham
  City/town Edgbaston
  Zip/Postcode B15 2TT
  Country United Kingdom
  Tel +44 (0)121 414 6420
  Fax +44 (0)121 414 7938
  Email j.v.parle@bham.ac.uk
Sponsor The Health Foundation (UK)
  Address 90 Long Acre
  City/town London
  Zip/Postcode WC2E 9RA
  Country United Kingdom
  Tel +44 (0)20 7257 8000
  Fax +44 (0)20 7257 8001
  Email info@health.org.uk
  Sponsor website: http://www.pppfoundation.org.uk/
Date applied 12/09/2002
Last edited 14/09/2007
Date ISRCTN assigned 12/09/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central